文献速递母胎医学产科

胎儿结构异常的产前外显子组和基因组测序

Prenatal exome and genome sequencing for fetal structural abnormalities.
PubMed 文献 · Am J Obstet Gynecol · 2022-08-24

本文综述产前外显子组测序在胎儿结构异常中的指征、方法、诊断率、临床效用、变异解读、伦理考量与困境、实践考量(如周转时间和成本)、检测前后咨询要点及检测对家庭的心理影响,强调应认识该技术的益处与挑战。

要点

  • 产前外显子组测序已融入临床实践,需认识其益处与挑战。
  • 综述涵盖指征、方法、诊断率、临床效用及变异解读。
  • 涉及伦理、实践考量、咨询要点及心理影响。

核心结论

  • 照护胎儿异常孕妇的医生应认识产前外显子组测序的益处及相关的挑战与考量。

研究设计与样本

  • 本文为综述,涵盖产前测序的指征、方法、诊断率、临床效用、变异解读、伦理考量与困境、实践考量、检测前后咨询要点及心理影响。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As prenatal exome sequencing becomes integrated into clinical care, it is critical that providers caring for women with fetal anomalies recognize not only the benefits, but also the challenges and considerations related to this technology. This overview of prenatal sequencing includes information about indications for sequencing, methods, diagnostic yield, clinical utility, variant interpretation, ethical considerations and dilemmas, practical considerations (ie, turnaround time and cost), pre- and posttest counseling points, and psychological impact of testing on families.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Vora NL, Norton ME. Prenatal exome and genome sequencing for fetal structural abnormalities. Am J Obstet Gynecol. 2022. PMID: 36027950. doi:10.1016/j.ajog.2022.08.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。